Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway

Journal of Virology
John B RuedasJohn H Connor

Abstract

The Zaire ebolavirus (EBOV) glycoprotein (GP) is cleaved into two subunits (GP1 and GP2) that are both required for virus attachment and entry into cells. Sequence changes in the GP have been proposed to increase pathogenesis and to alter virus growth properties. Mutations in GP acquired during EBOV tissue culture passage have also been reported to change virus growth properties. Here, we report the isolation of six amino acid mutations in EBOV GP that spontaneously appeared during recovery and passage of an EBOV-Makona GP-pseudotyped vesicular stomatitis virus (VSV), two of which also occur during passage of EBOV clinical isolates in tissue culture. Each of the six mutations resulted in increased virus growth in monkey and human cell lines. All mutations are located in the GP2 fusion subunit and increase entry kinetics of EBOV virus-like particles (VLPs). The gain-of-entry function mapped to two mechanistic phenotypes. Mutations in heptad repeat 1 (HR1) decreased the requirement for cathepsin B activity for viral infection. Mutations directly within the fusion loop increased entry kinetics without altering the cathepsin B dependence. Several mutations in the fusion loop were substitutions of residues present in other ebolaviru...Continue Reading

References

May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·V E VolchkovH D Klenk
Feb 13, 1999·The Journal of Infectious Diseases·T MaruyamaD R Burton
Nov 20, 2002·Journal of Virology·Scott A JeffersAnthony Sanchez
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Apr 16, 2005·Science·Kartik ChandranJames M Cunningham
Apr 11, 2006·The Journal of General Virology·Nathalie Alazard-DanyViktor E Volchkov
Jan 9, 2008·BMC Genomics·Appolinaire DjikengDavid J Spiro
Jan 1, 2009·Future Virology·Jeffrey E Lee, Erica Ollmann Saphire
Feb 1, 2011·Bioinformatics·Robert Schmieder, Robert Edwards
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sonia M GregoryLukas K Tamm
Aug 26, 2011·Nature·Jan E CaretteThijn R Brummelkamp
Oct 19, 2011·The Journal of Infectious Diseases·Valentina A VolchkovaViktor E Volchkov
Mar 8, 2012·The EMBO Journal·Emily Happy MillerKartik Chandran
Dec 14, 2012·PLoS Neglected Tropical Diseases·Andrea MarziHeinz Feldmann
Apr 4, 2014·Journal of Virology·Sonia M GregoryLukas K Tamm
Apr 18, 2014·The New England Journal of Medicine·Sylvain BaizeStephan Günther
Aug 30, 2014·Nature·Xiangguo QiuGary P Kobinger
Mar 27, 2015·The Journal of Infectious Diseases·Yoshimi TsudaHideki Ebihara
May 15, 2015·Nature·Yi-Gang TongUNKNOWN China Mobile Laboratory Testing Team in Sierra Leone
Aug 28, 2015·Journal of Virology·Edgar DavidsonBenjamin J Doranz
Dec 5, 2017·Bulletin of the World Health Organization·Stania KamaraAndrew Muana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.